Phase I trial of temozolomide plus O6-benzylguanine 5-day regimen with recurrent malignant glioma

Authors:

Abstract
This phase I clinical trial conducted with patients who had recurrent or progressive malignant glioma (MG) was designed to determine the maximum tole

This publication has 16 references indexed in Scilit: